KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.

Br J Cancer · 2015 · PMC4333487 · PMID 25688918

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not achieve significanceno p-value reported

Furthermore, adjuvant treatment following thoracic surgery, adjuvant treatment during the time period immediately before or after CRC surgery and the number of thoracic metastases did not achieve significance in the multivariate analysis.

also in 1,397 other papers

approaching significanceno p-value reported

Patients who underwent neo-adjuvant chemotherapy before CRC surgery exhibited a worse OS ( P =0.07); however, this result was not significant, only approaching significance.

also in 2,640 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.